Boehringer Ingelheim

Senior SIEM Engineer for Cybersecurity Detection

Boehringer Ingelheim
Apply
2 months ago
Philippines (city not specified)Senior

Responsibilities

  • Implement and fine-tune SIEM/XDR security use cases to improve detection effectiveness and reduce false positives.
  • Develop, maintain, and enhance scripts and API integrations that leverage or enrich SIEM/XDR technologies.
  • Support breach and attack simulation threat creation to automatically test and improve security use cases.
  • Evolve current security technologies according to the defined roadmap.
  • Collaborate with Security Detection and Incident Response teams to improve detection capabilities.
  • Manage and deliver security monitoring reports and dashboards.
  • Maintain required compliance documentation in accordance with SOPs and working instructions.
  • Present security monitoring status and updates to technology subject matter experts and management.

Requirements

  • Proven experience developing security use cases for SIEM/XDR technologies such as Splunk Enterprise Security, Microsoft Sentinel, or Microsoft Defender.
  • Programming experience with Python, PowerShell, and Bash, including API integration.
  • Desired experience creating breach and attack simulation threats.
  • Experience with reporting and ticketing platforms such as ServiceNow.
  • Knowledge of common security weaknesses, remediation processes, prioritization, change management, analysis, and triage.
  • Security certifications such as Security+ CE, GCIH, ECIH, OSCP, or CEH are desirable but not mandatory.
  • Excellent spoken and written English and experience working in virtual, international, and multicultural environments.
  • Strong analytical thinking, communication, problem-solving, results-oriented, agility, and teamwork skills.

Tech Stack

BashPowerShellPython

Categories

Boehringer Ingelheim

About Boehringer Ingelheim

10,000+ employees

Boehringer Ingelheim develops and manufactures prescription medicines for humans and animal health products, and provides biopharmaceutical contract manufacturing services. The family-owned company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. Its portfolio spans areas such as cardiovascular and metabolic diseases, respiratory disorders, oncology, and vaccines for livestock and companion animals, with products marketed globally.

Contact me